Research Study

Myo-inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline-induced pulmonary hypertension in the rat.

📅 2024 🔗 DOI: 10.1111/bph.16482
Citation
Oknińska M., Paterek A., Grzanka M., Zajda K., Surzykiewicz M. et al. (2024). Myo-inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline-induced pulmonary hypertension in the rat.. Br J Pharmacol. DOI: 10.1111/bph.16482
View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.